XML 57 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings per Share / Unit (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Computation of Net Income per Share on Basic and Diluted Basis
The following table reflects the Company’s computation of net income per common share on a basic and diluted basis for the three and six months ended June 30, 2023 and 2022 (amounts in thousands, except share and per share data):
For the Three Months Ended
June 30,
For the Six Months Ended
June 30,
 2023202220232022
Numerator:    
Net income$115,414 $74,555 $253,113 $144,569 
Less:
Noncontrolling interest 13,899 8,343 30,647 16,655 
Dividends on preferred shares3,486 4,346 6,972 10,109 
Redemption of perpetual preferred shares— 5,276 — 5,276 
Allocation to participating securities (1)
288 198 633 395 
Numerator for income per common share–basic and diluted$97,741 $56,392 $214,861 $112,134 
Denominator:
Weighted-average common shares outstanding–basic362,148,911 348,484,158 361,267,035 347,123,576 
Effect of dilutive securities:
Share-based compensation plan and forward sale equity contracts (2)
331,031 518,466 326,139 628,382 
Weighted-average common shares outstanding–diluted (3)
362,479,942 349,002,624 361,593,174 347,751,958 
Net income per common share:
Basic$0.27 $0.16 $0.59 $0.32 
Diluted$0.27 $0.16 $0.59 $0.32 
(1)Unvested RSUs that have nonforfeitable rights to participate in dividends declared on common stock are accounted for as participating securities and reflected in the calculation of basic and diluted earnings per share using the two-class method.
(2)Reflects the effect of potentially dilutive securities issuable upon the assumed exercise of stock options for the three and six months ended June 30, 2023 and 2022 and the dilutive effect of forward sale equity contracts under the treasury stock method for the three and six months ended June 30, 2022 (see Note 10. Shareholders’ Equity / Partners’ Capital).
(3)The effect of the potential conversion of OP units is not reflected in the computation of basic and diluted earnings per share, as they are exchangeable for Class A common shares on a one-for-one basis. The income allocable to the OP units is allocated on this same basis and reflected as noncontrolling interest in the accompanying condensed consolidated financial statements. As such, the assumed conversion of the OP units would have no net impact on the determination of diluted earnings per share.
The following table reflects the Operating Partnership’s computation of net income per common unit on a basic and diluted basis for the three and six months ended June 30, 2023 and 2022 (amounts in thousands, except unit and per unit data):
For the Three Months Ended
June 30,
For the Six Months Ended
June 30,
 2023202220232022
Numerator:    
Net income$115,414 $74,555 $253,113 $144,569 
Less:
Preferred distributions3,486 4,346 6,972 10,109 
Redemption of perpetual preferred units— 5,276 — 5,276 
Allocation to participating securities (1)
288 198 633 395 
Numerator for income per common unit–basic and diluted$111,640 $64,735 $245,508 $128,789 
Denominator:
Weighted-average common units outstanding–basic413,525,891 399,861,138 412,644,015 398,500,556 
Effect of dilutive securities:
Share-based compensation plan and forward sale equity contracts (2)
331,031 518,466 326,139 628,382 
Weighted-average common units outstanding–diluted413,856,922 400,379,604 412,970,154 399,128,938 
Net income per common unit:
Basic$0.27 $0.16 $0.59 $0.32 
Diluted$0.27 $0.16 $0.59 $0.32 
(1)Unvested RSUs that have nonforfeitable rights to participate in dividends declared on common stock are accounted for as participating securities and reflected in the calculation of basic and diluted earnings per unit using the two-class method.
(2)Reflects the effect of potentially dilutive securities issuable upon the assumed exercise of stock options for the three and six months ended June 30, 2023 and 2022 and the dilutive effect of forward sale equity contracts under the treasury stock method for the three and six months ended June 30, 2022 (see Note 10. Shareholders’ Equity / Partners’ Capital).